271 related articles for article (PubMed ID: 25534870)
1. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma.
Zhang Y; Shao J; Wang Z; Yang T; Liu S; Liu Y; Fan X; Ye W
Gene; 2015 Feb; 557(2):209-14. PubMed ID: 25534870
[TBL] [Abstract][Full Text] [Related]
2. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
[TBL] [Abstract][Full Text] [Related]
3. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 11 locally controls anterior-posterior patterning of the axial skeleton.
Suh J; Eom JH; Kim NK; Woo KM; Baek JH; Ryoo HM; Lee SJ; Lee YS
J Cell Physiol; 2019 Dec; 234(12):23360-23368. PubMed ID: 31183862
[TBL] [Abstract][Full Text] [Related]
5. Impact of targeted PPARγ disruption on bone remodeling.
Cao J; Ou G; Yang N; Ding K; Kream BE; Hamrick MW; Isales CM; Shi XM
Mol Cell Endocrinol; 2015 Jul; 410():27-34. PubMed ID: 25666993
[TBL] [Abstract][Full Text] [Related]
6. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11.
McPherron AC; Lawler AM; Lee SJ
Nat Genet; 1999 Jul; 22(3):260-4. PubMed ID: 10391213
[TBL] [Abstract][Full Text] [Related]
7. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
[TBL] [Abstract][Full Text] [Related]
8. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta/Smad signalling pathway.
Luo H; Guo Y; Liu Y; Wang Y; Zheng R; Ban Y; Peng L; Yuan Q; Liu W
Cell Prolif; 2019 Jul; 52(4):e12631. PubMed ID: 31038259
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 11 promotes differentiation of MSCs into endothelial-like cells for angiogenesis.
Zhang C; Lin Y; Liu Q; He J; Xiang P; Wang D; Hu X; Chen J; Zhu W; Yu H
J Cell Mol Med; 2020 Aug; 24(15):8703-8717. PubMed ID: 32588524
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency.
Ahn ST; Suh SI; Moon H; Hyun C
Can J Vet Res; 2016 Jan; 80(1):90-2. PubMed ID: 26733738
[TBL] [Abstract][Full Text] [Related]
12. Redundancy of myostatin and growth/differentiation factor 11 function.
McPherron AC; Huynh TV; Lee SJ
BMC Dev Biol; 2009 Mar; 9():24. PubMed ID: 19298661
[TBL] [Abstract][Full Text] [Related]
13. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).
Duque G; Macoritto M; Kremer R
Exp Gerontol; 2004 Mar; 39(3):333-8. PubMed ID: 15036392
[TBL] [Abstract][Full Text] [Related]
14. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.
Muruganandan S; Roman AA; Sinal CJ
J Bone Miner Res; 2010 Feb; 25(2):222-34. PubMed ID: 19929432
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.
Wei W; Dutchak PA; Wang X; Ding X; Wang X; Bookout AL; Goetz R; Mohammadi M; Gerard RD; Dechow PC; Mangelsdorf DJ; Kliewer SA; Wan Y
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3143-8. PubMed ID: 22315431
[TBL] [Abstract][Full Text] [Related]
16. Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation.
Weivoda MM; Hohl RJ
Bone; 2012 Feb; 50(2):467-76. PubMed ID: 22019459
[TBL] [Abstract][Full Text] [Related]
17. Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra.
Li Z; Kawasumi M; Zhao B; Moisyadi S; Yang J
Mol Reprod Dev; 2010 Nov; 77(11):990-7. PubMed ID: 21049546
[TBL] [Abstract][Full Text] [Related]
18. GDF11 prevents the formation of thoracic aortic dissection in mice: Promotion of contractile transition of aortic SMCs.
Ren K; Li B; Liu Z; Xia L; Zhai M; Wei X; Duan W; Yu S
J Cell Mol Med; 2021 May; 25(10):4623-4636. PubMed ID: 33764670
[TBL] [Abstract][Full Text] [Related]
19. Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb.
Gamer LW; Cox KA; Small C; Rosen V
Dev Biol; 2001 Jan; 229(2):407-20. PubMed ID: 11203700
[TBL] [Abstract][Full Text] [Related]
20. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development.
Harmon EB; Apelqvist AA; Smart NG; Gu X; Osborne DH; Kim SK
Development; 2004 Dec; 131(24):6163-74. PubMed ID: 15548585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
